Telomerase activating compounds for use in fertility and related applications
Grant
US12576047B2
Kind: B2
Mar 17, 2026
Assignee
Neuromagen Pharma Ltd
Inventors
Esther Priel
Abstract
The present invention is directed to methods and uses of a series of compounds and compositions comprising the same for treating diseases, disorders and/or conditions related to fertility and preserving same and conditions related to same. In some aspects, the compounds and or compositions as herein described promote, improve, recover or restore fertility in a subject in need thereof, including in male and/or female subjects. Such methods/uses include promoting, enhancing or improving fertility-associated cell or tissue yield as part of an in vitro fertilization protocol.
CPC Classifications
A61K 31/05
A61K 31/055
A61K 31/09
A61K 31/137
A61K 31/4025
A61K 31/4545
A61K 31/496
A61K 31/5377
A61K 31/66
A61P 15/00
A61P 15/08
A61P 35/00
A61P 43/00
Filing Date
2023-08-25
Application No.
18456178
Claims
13